Finerenone for heart rhythm stability in preserved ejection fraction heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether finerenone, a medication that may help the heart work better, can improve electrical stability in people with a certain type of heart failure (HFpEF). It aims to reduce irregular heart rhythms and improve overall heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have heart failure with preserved ejection fraction (a type of heart failure where the heart's pumping function is normal but it doesn't fill properly).
- You have a normal heart rhythm (sinus rhythm) as shown by an ECG and Holter monitor.
- You do not have a history of atrial fibrillation or other irregular heart rhythms.
- You do not have certain heart conduction problems or a pacemaker that paces the upper chambers.
- Your kidney function is not severely reduced (eGFR of at least 25).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking finerenone after a heart procedure to fix irregular heartbeat can help prevent atrial fibrillation from coming back. It's for people having their first such procedure and aims to improve long-term heart rhythm health.
This trial tests a medication called Finerenone to see if it can improve heart structure and function in people with both diabetic kidney disease and heart failure. If you have type 2 diabetes, kidney problems, and heart failure with preserved pumping function, this study may explore a new treatment option for you.
This trial tests a new medicine called finerenone to see if it can reduce heart scarring and improve heart function in people with a certain type of heart failure (preserved ejection fraction). If you qualify, you may help researchers learn if this treatment can help you feel better and stay out of the hospital.
This trial tests a medication called finerenone to see if it helps people hospitalized for heart failure live longer and have fewer heart-related problems. It may be an option for those with a certain type of heart failure where the heart's pumping strength is mildly reduced or normal.
This study tests a new drug called finerenone to see if it can improve heart function in people with a type of heart failure where the heart pumps normally but is stiff. It may help reduce symptoms and improve quality of life.
This study tests whether finerenone, a new type of drug, can help people with heart failure who cannot take standard steroid-based MRAs (a kind of heart medication) because of side effects or other reasons. It aims to see if it improves symptoms and is safe for you.
Hear when a new Arrythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.